Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

G. Rosati, G. Aprile, Mario Scartozzi, F. Pasini, M. Cantore, D. Ferrari, S. Barni, R. Labianca, TOSCA (Three or Six Colon Adjuvant) Investigators, Guglielmo Nasti, Rosario Vincenzo Iaffaioli

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)2074-2081
Number of pages8
JournalAnnals of Oncology
Volume27
Issue number11
DOIs
Publication statusPublished - Nov 1 2016

Keywords

  • Journal Article

Cite this